About Us

arrow-icon
Back to About Us
member-photo-1

Donna Harrison, M.D.

Associate Scholar

Dr. Donna Harrison is a physician, board-certified in obstetrics and gynecology.  She is currently serving as Chief Executive Officer of the American Association of Pro-Life Obstetricians and Gynecologists, the largest non-sectarian pro-life physician organization in the world, with over 6000 members across the United States, and associate members on every continent. Under her leadership, AAPLOG has doubled membership, launched the annual Matthew Bulfin Educational Conference, developed an up-to-date website and social media presence, and launched systematic outreaches to the medical, legal and policy communities to discuss the effects of abortion on women.

Dr. Harrison’s research interests include selective progesterone receptor modulators, endometrial contraception, maternal mortality, and abortion mortality and morbidity. She has authored peer reviewed papers on maternal mortality, mifeprex abortion mortality and morbidity, the approval of RU-486 and Ulipristal (Ella) as well as other topics concerning endometrial contraception. Dr. Harrison is a Continuing Medical Education Speaker in the United States and internationally on topics of Medical Abortion with Mifepristone and Misoprostol, Adverse Events associated with Mifepristone and Misoprostol, Emergency Contraception with Ulipristal, Maternal Mortality, and Abortion Morbidity.

She is an Adjunct Professor at Trinity International University in Deerfield, IL, teaching post graduate seminars at the annual Center for Bio Ethics and Human Dignity summer workshops. She is Associate Editor of the peer reviewed medical journal “Issues in Law and Medicine”.

Dr. Harrison is married to a fellow physician and is the mother of 5 children and 5 grandchildren.

 

Latest Research & News

  • Questions and Answers on Late-Term Abortion | May 16, 2022

    First published: February 2019 Last updated: May 16, 2022   To view this fact sheet as a PDF, see: Fact Sheet: Questions and Answers on Late-Term Abortion   What is a Late-Term Abortion?   “Late-term” abortion is an imprecise term, but under any “formal” definition offered or as accepted by the public at large late-term […]

  • Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions | December 16, 2021

    By: David C. Reardon, Ph.D., Donna J. Harrison M.D., Ingrid Skop M.D. Maka Tsulukidze, M.D., Ph.D, M.P.H.,Christina A. Cirucci, M.D., James Studnicki, Sc.D., M.P.H. M.B.A   This is issue 20 of CLI’s American Report Series. To View this Report as a PDF, see: Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: […]

  • Abortion Pill Reversal: A Second Chance at Choice | April 17, 2018

    A new and groundbreaking study has thrown the U.S. abortion establishment into a tizzy, and it’s easy to understand why.   For years, proponents of medication abortion (or chemical abortion, as some call it) have criticized a protocol aimed at reversing drug-induced abortions on the primary ground that the number of cases where such reversals […]

  • National Academies Report Downplays the Health Risks of Abortion | March 29, 2018

      Earlier this month, the National Academies of Sciences, Engineering, and Medicine (NAS) released a report on the safety of abortion in the United States. It examines various methods used for abortion and concludes that abortion is safe and poses minimal health risks. The report also puts a negative spin on pro-life laws, arguing that many of […]

  • Rewire’s Reckless Push for Mail-Order Mifeprex | December 1, 2017

    To view this paper as a PDF, see: Rewire’s Reckless Push for Mail-Order Mifeprex   In pursuit of the possibility that abortion drugs could be distributed via pharmacies or mail order shipment for at-home use, researchers from a group called Gynuity Health Projects sought RU-486 online from 20 websites and had them tested for their potency […]

  • Abortion Increases Risk of Preterm Birth: More Evidence in New Publication | May 13, 2016

    The recent systematic review published by Gabrielle Saccone and colleagues joins the long list of over 150 studies over the past four decades which extensively document that having an induced abortion increases a woman’s risk of preterm birth in subsequent pregnancies. Saccone et al. clearly document again what other authors have repeatedly published; a fact also acknowledged by the Institute of Medicine (IOM) in their report on preterm birth in 2005. However, unlike the IOM, who hid the association on page 625 in Appendix B, Saccone places the facts in the open: “Prior surgical uterine evacuation for either I-TOP [induced termination of pregnancy] or SAB [spontaneous abortion] is an independent risk factor for PTB [preterm birth].” Translated, that means any time the womb of a pregnant woman is forced open, there is a risk of damaging the opening of the womb.

  • Good News for Pregnant Moms Diagnosed with Cancer, and Good News for their Unborn Babies | October 20, 2015

    Separation of a mother and her unborn child is tragically sometimes necessary to save the life of the mother. But the number of conditions which truly threaten the mother’s life, and which require a life-saving separation of the mother and her baby are vanishingly small. A new study by Amant and colleagues, entitled “Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy,” brings tremendous hope to pregnant women who have courageously carried their unborn children to birth, despite the need for chemotherapy or radiation therapy. And the successful outcome of these children exposed in utero to radiation, chemotherapy or a combination of both is reassuring to pregnant women who no longer need be told outdated information that they must abort their children or else risk compromising their own care or their child’s life.